2017
DOI: 10.1080/10408398.2017.1362630
|View full text |Cite
|
Sign up to set email alerts
|

Lycopene and tomato and risk of cardiovascular diseases: A systematic review and meta-analysis of epidemiological evidence

Abstract: This comprehensive meta-analysis suggests that high-intakes or high-serum concentration of lycopene are associated with significant reductions in the risk of stroke (26%), mortality (37%) and CVDs (14%).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
67
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 128 publications
(70 citation statements)
references
References 63 publications
1
67
0
2
Order By: Relevance
“…Lycopene has several cardiovascular beneficial effects, such as an antioxidative, antiinflammatory, anti-atherogenic, cardioprotective, and antiplatelet effect, improving endothelial function (nitric oxide bioavailability and blood flow), the metabolic profile (by impairing cholesterol synthesis) and blood pressure control (Figure 2 ) (Klipstein-Grobusch et al, 2000 ; Heber and Lu, 2002 ; Ahuja et al, 2006 ; Basu and Imrhan, 2007 ; Verghese et al, 2008 ; Kim et al, 2010 ; Kong et al, 2010 ; Riccioni et al, 2010 ; Ried and Fakler, 2011 ; Böhm, 2012 ; Wolak and Paran, 2013 ; Gajendragadkar et al, 2014 ; Naz et al, 2014 ; Müller et al, 2016 ; Cheng et al, 2017 ; Milani et al, 2017 ).…”
Section: Cardiovascular Protective Mechanismsmentioning
confidence: 99%
See 2 more Smart Citations
“…Lycopene has several cardiovascular beneficial effects, such as an antioxidative, antiinflammatory, anti-atherogenic, cardioprotective, and antiplatelet effect, improving endothelial function (nitric oxide bioavailability and blood flow), the metabolic profile (by impairing cholesterol synthesis) and blood pressure control (Figure 2 ) (Klipstein-Grobusch et al, 2000 ; Heber and Lu, 2002 ; Ahuja et al, 2006 ; Basu and Imrhan, 2007 ; Verghese et al, 2008 ; Kim et al, 2010 ; Kong et al, 2010 ; Riccioni et al, 2010 ; Ried and Fakler, 2011 ; Böhm, 2012 ; Wolak and Paran, 2013 ; Gajendragadkar et al, 2014 ; Naz et al, 2014 ; Müller et al, 2016 ; Cheng et al, 2017 ; Milani et al, 2017 ).…”
Section: Cardiovascular Protective Mechanismsmentioning
confidence: 99%
“…This can be explained by the insight that increased fecal excretion impairs the enterohepatic circuit of bile acids, thus increasing the conversion of cholesterol to bile acids (Verghese et al, 2008 ). The lipid lowering properties of lycopene involve also an increased activity of LDL receptors in macrophages (Li et al, 2015 ; Cheng et al, 2017 ).…”
Section: Cardiovascular Protective Mechanismsmentioning
confidence: 99%
See 1 more Smart Citation
“…Lycopene is a major dietary carotenoid protecting cells against oxidative damage to lipids, proteins, and DNA [1,2].…”
Section: Introductionmentioning
confidence: 99%
“…In a recent systematic review and meta-analysis, it was reported that the highest consumption category with the highest serum concentration of lycopene had significantly lower risk of stroke (26%), mortality (37%), and CVDs (14%), but limited or no association of lycopene with atherosclerosis, congestive heart failure or atrial fibrillation. Lycopene was not significantly associated with myocardial infarction [128]. Hereafter, more reliable clinical trials, consisting of welldesigned clinical trials, are clearly necessary using larger and longer studies to better delineate the therapeutic role of Lycopene in human.…”
Section: Clinical Studiesmentioning
confidence: 99%